Rituxem 100mg Injection

About

Rituximab is a chimeric monoclonal antibody that specifically targets the CD20 protein, a transmembrane antigen found on the surface of pre-B and mature B lymphocytes. Its mechanism of action involves binding to CD20, which subsequently triggers a cascade of immune responses, including antibody-dependent cell-mediated cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and direct induction of apoptosis, leading to the depletion of CD20-positive B cells. This targeted B-cell depletion is crucial in managing various autoimmune diseases, such as rheumatoid arthritis and certain vasculitides, where B cells contribute to inflammation and autoantibody production. Additionally, rituximab is highly effective in treating specific hematological malignancies, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia, by eliminating cancerous B-cell populations. Its precise immunological targeting offers a significant therapeutic advantage, helping to reduce disease activity, induce remission, and improve long-term outcomes for patients with these complex conditions.

Uses

• Non-Hodgkin's lymphoma
• Chronic lymphocytic leukemia
• Rheumatoid arthritis
• Granulomatosis with polyangiitis

Directions For Use

Administered intravenously by a healthcare professional. Dosage and frequency are determined by the treating physician based on the specific condition.

Benefits

• Targets specific immune cells (B-cells)
• Reduces disease activity in autoimmune conditions
• Effective in certain hematological malignancies
• Can induce long-term remission
• Improves quality of life for patients
• Often used in combination therapies

Side Effects

• Infusion-related reactions (fever, chills, nausea)
• Fatigue
• Headache
• Nausea
• Diarrhea
• Peripheral edema
• Increased risk of infection
• Hypotension
• Pruritus
• Rash
• Muscle spasms
• Neutropenia

Safety Measures

• Alcohol - Alcohol consumption should be discussed with your doctor, as it may exacerbate some side effects or interact with your underlying condition.
• Pregnancy - Rituximab is generally not recommended during pregnancy due to potential fetal harm; effective contraception is advised for women of childbearing potential.
• Breastfeeding - Breastfeeding is generally not recommended during treatment and for a period after the last dose, as rituximab may pass into breast milk.
• Liver - Use with caution in patients with pre-existing liver conditions; liver function should be monitored regularly during treatment.
• Kidney - No specific dose adjustment is typically required for mild to moderate renal impairment, but caution is advised, and monitoring is recommended.
• Lung - Patients with pre-existing lung conditions should be monitored closely for pulmonary adverse events, including interstitial lung disease.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.